Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: Sadif Analytics Prime
$25.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Boiron SA's Unda to Reorganize Its Activities


Tuesday, 4 Jun 2013 01:00pm EDT 

Boiron SA announced that its subsidiary Unda intents to reorganize its activities in order to ensure the development of homeopathy in Belgium. It is planned to create two different companies in order to develop Unda's medicines and the Company's medicines independently. It is also planned to look for a buyer able to sustain the activity of Unda in Belgium and abroad. 

Related Company News

Company Quote

69.6
0.69 +1.00%
11:35am EST